VOYA INVESTMENT MANAGEMENT LLC

Position in CCCC — C4 Therapeutics, Inc.

CIK 1068837 ATLANTA, GA

Position in CCCC

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$90,560

+$62,845 QoQ

Shares Held

19,392

+12.0% QoQ

Ownership

0.016%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#104

of 147 holders

Holding Since

Jun 2021

13 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

VOYA INVESTMENT MANAGEMENT LLC holds $1,414,582,516 across 196 Biotechnology names. CCCC ranks #158 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	505,219	$250,957,432
2	PTGX	Protagonist Therapeutics, Inc	571,618	$70,068,932
3	SRRK	Scholar Rock Holding Corp	890,607	$48,983,385
4	KRYS	Krystal Biotech, Inc.	124,442	$46,251,357
5	TGTX	Tg Therapeutics, Inc.	819,253	$45,009,759
6	PTCT	Ptc Therapeutics, Inc.	539,319	$43,992,249
7	PRAX	Praxis Precision Medicines, Inc.	122,227	$40,920,376
8	REGN	Regeneron Pharmaceuticals, Inc.	65,505	$40,844,986

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$90,560	19,392	+12.0%	Shares	Defined	2026-08-12
2025-03-31	$27,715	17,322	-5.2%	Shares	Defined	2025-06-18
2024-12-31	$65,797	18,277	-6.2%	Shares	Defined	2025-05-02
2024-09-30	$111,041	19,481	-1.3%	Shares	Defined	2025-02-07
2024-06-30	$91,175	19,735	+19.9%	Shares	Defined	2025-02-07
2023-03-31	$51,678	16,458	0.0%	Shares	Defined	2025-02-07
2022-12-31	$97,102	16,458	0.0%	Shares	Defined	2025-02-07
2022-09-30	$144,336	16,458	+8.6%	Shares	Defined	2025-02-07
2022-06-30	$114,313	15,161	0.0%	Shares	Defined	2022-08-15
2022-03-31	$367,805	15,161	0.0%	Shares	Defined	2022-05-16
2021-12-31	$488,184	15,161	+2.0%	Shares	Defined	2022-02-14
2021-09-30	$664,123	14,864	+9.6%	Shares	Defined	2021-11-15
2021-06-30	$513,110	13,560	—	Shares	Defined	2021-08-16
No filing history on record for this holder in this stock.